DOCSLIB.ORG

Biochemistrystanford00kornrich.Pdf

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Biochemistrystanford00kornrich.Pdf University of California Berkeley Regional Oral History Office University of California The Bancroft Library Berkeley, California Program in the History of the Biosciences and Biotechnology Arthur Kornberg, M.D. BIOCHEMISTRY AT STANFORD, BIOTECHNOLOGY AT DNAX With an Introduction by Joshua Lederberg Interviews Conducted by Sally Smith Hughes, Ph.D. in 1997 Copyright 1998 by The Regents of the University of California Since 1954 the Regional Oral History Office has been interviewing leading participants in or well-placed witnesses to major events in the development of Northern California, the West, and the Nation. Oral history is a method of collecting historical information through tape-recorded interviews between a narrator with firsthand knowledge of historically significant events and a well- informed interviewer, with the goal of preserving substantive additions to the historical record. The tape recording is transcribed, lightly edited for continuity and clarity, and reviewed by the interviewee. The corrected manuscript is indexed, bound with photographs and illustrative materials, and placed in The Bancroft Library at the University of California, Berkeley, and in other research collections for scholarly use. Because it is primary material, oral history is not intended to present the final, verified, or complete narrative of events. It is a spoken account, offered by the interviewee in response to questioning, and as such it is reflective, partisan, deeply involved, and irreplaceable. ************************************ All uses of this manuscript are covered by a legal agreement between The Regents of the University of California and Arthur Kornberg, M.D., dated June 18, 1997. The manuscript is thereby made available for research purposes. All literary rights in the manuscript, including the right to publish, are reserved to The Bancroft Library of the University of California, Berkeley. No part of the manuscript may be quoted for publication without the written permission of the Director of The Bancroft Library of the University of California, Berkeley. Requests for permission to quote for publication should be addressed to the Regional Oral History Office, 486 Library, University of California, Berkeley 94720, and should include identification of the specific passages to be quoted, anticipated use of the passages, and identification of the user. The legal agreement with Arthur Kornberg, M.D., requires that he be notified of the request and allowed thirty days in which to respond. It is recommended that this oral history be cited as follows: Arthur M.D. Kornberg, , "Biochemistry at Stanford, Biotechnology at DNAX," an oral history conducted in 1997 by Sally Smith Hughes, Ph.D., Regional Oral History Office, The Bancroft Library, University of California, Berkeley, 1998. Copy no. Arthur Kornberg, ca. 1987, Cataloguing information Arthur Kornberg, M.D. (b. 1918) Biochemist Biochemistry at Stanford and Biotechnology at DNAX. 1998, xiv, 268pp. Early career at National Institutes of Health: nutrition research, mentored by Severo Ochoa and Carl Cori; chairman, microbiology, Washington University, St. Louis: C.B. van Niel's microbiology course, faculty, Erwin Chargaff, nucleotide chain synthesis research, DNA as genetic material; chairman, biochemistry, Stanford University: renovation of Stanford Medical School, founding and staffing of biochemistry department, interaction of basic and clinical sciences, departmental operational style, new biochemistry curriculum, industry ties, Industrial Affiliates Program; research programs: DNA polymerase, DNA replication, viral synthesis, polyphosphate, Nobel prize; recombinant DNA: Senate testimony, 1968, patenting in biotechnology, controversy, Stanford biochemistry contributions to/failure to recognize commercial potential of, Peter Lobban's research on; ALZA Corporation; DNAX: foundation, funding, and staffing, purchase by interactions with Schering-Plough, antibody and interleukin research; anti-Semitism; Paul Berg; Dale Kaiser. Introduction by Joshua Lederberg, Ph.D., Rockefeller University, New York. Interviewed 1997 by Sally Smith Hughes for the Program in the History of the Biosciences and Biotechnology, Regional Oral History Office, The Bancroft Library, University of California, Berkeley. TABLE OF CONTENTS --Arthur Kornberg, M.D. PREFACE i INTRODUCTION by Joshua Lederberg vi INTERVIEW HISTORY x BIOGRAPHICAL INFORMATION xiv I EARLY CAREER AT THE NATIONAL INSTITUTES OF HEALTH 1 Research in Nutrition 1 Mentors 2 II CHAIRMAN, DEPARTMENT OF MICROBIOLOGY, WASHINGTON UNIVERSITY SCHOOL OF MEDICINE, ST. LOUIS, 1953-1959 5 Decision to Leave the National Institutes of Health [NIH] 5 Cornelius B. van Niel's Course in General Microbiology 6 Teaching Microbiology to Medical Students 7 Members of the Department 9 Erwin Chargaff and Base Pairing 12 Early Work on Nucleotide Chain Synthesis 13 DNA as the Genetic Material 14 Jacques Monod and DNA Polymerase 16 Obtaining Diverse Scientific Expertise 16 III CHAIRMAN, DEPARTMENT OF BIOCHEMISTRY, STANFORD MEDICAL SCHOOL, 1959-1969 18 Renovation of Stanford Medical School 18 The University Administration 18 Creation of the Biochemistry Department 18 Offer of the Chairmanship, 1957 19 Recruiting Other Major Scientists 20 Reluctance to Establish Joint Appointments 22 Relations with Clinical Scientists 23 Financial Aspects 25 Tensions 26 The New Department of Biochemistry 27 Choosing Faculty Members 27 Leaving St. Louis 29 Melvin Cohn 30 Relations with the Two Biochemists in the Chemistry Department 32 Communal Structure 32 Later Changes in Departmental Faculty 34 Interaction Between the Basic and Clinical Sciences at Stanford 37 Limited Success 37 The Beckman Center for Molecular and Genetic Medicine 37 Clinicians as Basic Scientists 38 Bridging the Basic Sciencies 40 The Medical Center as an Intrusion 40 The Basic Science Environment, circa 1959 41 Later Efforts to Strengthen Basic Science at Stanford 42 Joshua Lederberg 43 More on the Department of Biochemistry at Stanford 44 Intellectual Focus on DNA 44 Joint Appointments 45 Broadening the Focus on DNA 45 The DNA Club 46 The Chairmanship 46 More on the Department's Distinctive Operational System 49 The Biochemistry Curriculum 51 The Laboratory for Medical Students, 1959-1965 51 The Medical Science Training Program 52 The Department's Relations with Industry 53 Industry Relations in Academic Science 53 Genesis of Biochemistry's Industrial Affiliates Program [IAP] 55 The Chemistry Department's Industrial Affiliates Program 56 Biochemistry's Industry Affiliates Program 57 Current Attitudes About Industrial Affiliations 59 Proposing a Scientists' Lobby 60 More on the Department's Program 61 More on the Chemistry Department's Program 62 Current Status of Biochemistry's IAP 63 Smith Kline & French 65 Potential Conflicts of Interest 66 Kornberg's Relationships with Industry 66 IV RESEARCH PROGRAMS 68 DNA as the Genetic Material 68 Research on DNA and RNA Polymerase 69 Joseph Fruton's Reaction to DNA Polymerase 71 E. coli Mutants Without Polymerase 72 Tom Kornberg's Contributions 74 Severe Ochoa's Research on RNA Polymerase 75 Kornberg's Research on DNA Synthesis 77 Synthesis of Viral DNA, 1967 79 Scientific and Popular Responses 79 Science and the Public 81 Publicist of Science 81 Advocate of Support for Basic Biomedical Research 82 Collaboration with Gobind Khorana 83 Changing Emphases in Biochemistry 85 Conference on the Chemical Basis of Heredity, 1956 87 More on the Synthesis of Viral DNA 88 Searching for Biological Activity 88 Sinsheimer's Phage Assay 90 Vitalism 91 Reductionism 92 Research on Polyphosphate 95 Attraction to the Field 95 Rejection at Berkeley 96 Medical and Developmental Implications 98 Unpopularity of the Research Field 99 More on DNA Polymerase 100 Early Interest in Nucleic Acids 100 More on Chargaff s and Avery's Contributions 102 More on Viral DNA Synthesis 103 Use of the Term "Genetic Engineering" 103 Trying to Produce a Biologically Active Molecule 104 Early Concerns About Genetic Engineering 106 Senate Testimony, March 1968 106 Critics of Genetic Engineering 107 Benefits and Dangers 108 The Nobel Prize 110 Stardom 110 Mistakes of Commission and Omission 111 Factors in the Nobel Committee's Decision 111 Drawbacks 113 Professional and University Service 114 Scientific Repercussions 115 RECOMBINANT DNA AND BIOTECHNOLOGY 117 Patenting in Biotechnology 117 Negative Influence on Academic Science 117 Secrecy in Industry 118 Decisions Regarding Product Development 119 Secrecy in Academia 120 Commercial Applications of Biology 120 Recombinant DNA Research 122 Concerns in the 1960s 122 Asilomar and the NIH Guidelines for Research on Recombinant DNA 124 Scientists Opposing Recombinant DNA Research 125 Concern about the A-T Polymer 126 Conference on Biohazards in Cancer Research, Asilomar, January 1973 127 The Moratorium 128 Potential for Scientific Research 128 An Interview with Dr. Kornberg in 1975 130 Controlling and Monitoring Research , 131 Potential Legislation 133 The Public's Role 135 The Department's Scientific Contributions 136 Dispersion of the Technology 137 Failure to Anticipate Commercial Applications 138 Industry Skepticism about Recombinant Products 139 Missing the Significance of the Lobban-Kaiser and Berg Research on Recombinant DNA 140 Peter Lobban's Research 140 Cohen and Boyer's Research 142 Mort Handel's Technique 143 Bestowing Credit on Lobban 144 Janet Mertz 145 Summary 146 Rewards and Omissions 147 The Pajaro Dunes Conference on Biotechnology, March 1982 148
Load more

Recommended publications
  • Unrestricted Immigration and the Foreign Dominance Of
    Unrestricted Immigration and the Foreign Dominance of United States Nobel Prize Winners in Science: Irrefutable Data and Exemplary Family Narratives—Backup Data and Information Andrew A. Beveridge, Queens and Graduate Center CUNY and Social Explorer, Inc. Lynn Caporale, Strategic Scientific Advisor and Author The following slides were presented at the recent meeting of the American Association for the Advancement of Science. This project and paper is an outgrowth of that session, and will combine qualitative data on Nobel Prize Winners family histories along with analyses of the pattern of Nobel Winners. The first set of slides show some of the patterns so far found, and will be augmented for the formal paper. The second set of slides shows some examples of the Nobel families. The authors a developing a systematic data base of Nobel Winners (mainly US), their careers and their family histories. This turned out to be much more challenging than expected, since many winners do not emphasize their family origins in their own biographies or autobiographies or other commentary. Dr. Caporale has reached out to some laureates or their families to elicit that information. We plan to systematically compare the laureates to the population in the US at large, including immigrants and non‐immigrants at various periods. Outline of Presentation • A preliminary examination of the 609 Nobel Prize Winners, 291 of whom were at an American Institution when they received the Nobel in physics, chemistry or physiology and medicine • Will look at patterns of
    [Show full text]
  • Como Citar Este Artigo Número Completo Mais Informações Do
    Encontros Bibli: revista eletrônica de biblioteconomia e ciência da informação ISSN: 1518-2924 Programa de Pós-graduação em Ciência da Informação - Universidade Federal de Santa Catarina STANFORD, Jailiny Fernanda Silva; SILVA, Fábio Mascarenhas e Prêmio Nobel como fator de influência nas citações dos pesquisadores: uma análise dos laureados de Química e Física (2005 - 2015) Encontros Bibli: revista eletrônica de biblioteconomia e ciência da informação, vol. 26, e73786, 2021, Janeiro-Abril Programa de Pós-graduação em Ciência da Informação - Universidade Federal de Santa Catarina DOI: https://doi.org/10.5007/1518-2924.2021.e73786 Disponível em: https://www.redalyc.org/articulo.oa?id=14768130002 Como citar este artigo Número completo Sistema de Informação Científica Redalyc Mais informações do artigo Rede de Revistas Científicas da América Latina e do Caribe, Espanha e Portugal Site da revista em redalyc.org Sem fins lucrativos acadêmica projeto, desenvolvido no âmbito da iniciativa acesso aberto Artigo Original Prêmio Nobel como fator de influência nas citações dos pesquisadores: uma análise dos laureados de Química e Física (2005 - 2015) Nobel Prize as an influencing factor in researchers' citations: an analysis of Chemistry and Physics laureates (2005 to 2015) Jailiny Fernanda Silva STANFORD Mestre em Ciência da Informação (PPGCI/UFPE) Bibliotecária-chefe Seminário Teológico Batista do Norte do Brasil (STBNB), Recife, Brasil [email protected] https://orcid.org/0000-0003-2112-6561 Fábio Mascarenhas e SILVA Doutor em Ciência da Informação (USP), Professor Associado Universidade Federal de Pernambuco, Departamento de Ciência da Informação, Recife, Brasil [email protected] https://orcid.org/0000-0001-5566-5120 A lista completa com informações dos autores está no final do artigo RESUMO Objetivo: Analisa a influência nos índices de citação por parte dos pesquisadores que foram contemplados pelo prêmio Nobel nas áreas da Física e Química no período de 2005 a 2015.
    [Show full text]
  • Discovery of DNA Structure and Function: Watson and Crick By: Leslie A
    01/08/2018 Discovery of DNA Double Helix: Watson and Crick | Learn Science at Scitable NUCLEIC ACID STRUCTURE AND FUNCTION | Lead Editor: Bob Moss Discovery of DNA Structure and Function: Watson and Crick By: Leslie A. Pray, Ph.D. © 2008 Nature Education Citation: Pray, L. (2008) Discovery of DNA structure and function: Watson and Crick. Nature Education 1(1):100 The landmark ideas of Watson and Crick relied heavily on the work of other scientists. What did the duo actually discover? Aa Aa Aa Many people believe that American biologist James Watson and English physicist Francis Crick discovered DNA in the 1950s. In reality, this is not the case. Rather, DNA was first identified in the late 1860s by Swiss chemist Friedrich Miescher. Then, in the decades following Miescher's discovery, other scientists--notably, Phoebus Levene and Erwin Chargaff--carried out a series of research efforts that revealed additional details about the DNA molecule, including its primary chemical components and the ways in which they joined with one another. Without the scientific foundation provided by these pioneers, Watson and Crick may never have reached their groundbreaking conclusion of 1953: that the DNA molecule exists in the form of a three-dimensional double helix. The First Piece of the Puzzle: Miescher Discovers DNA Although few people realize it, 1869 was a landmark year in genetic research, because it was the year in which Swiss physiological chemist Friedrich Miescher first identified what he called "nuclein" inside the nuclei of human white blood cells. (The term "nuclein" was later changed to "nucleic acid" and eventually to "deoxyribonucleic acid," or "DNA.") Miescher's plan was to isolate and characterize not the nuclein (which nobody at that time realized existed) but instead the protein components of leukocytes (white blood cells).
    [Show full text]
  • The Lock-And-Key Analogy in 20Th Century Biochemistry
    From: Rebecca Mertens The Construction of Analogy-Based Research Programs The Lock-and-Key Analogy in 20th Century Biochemistry April 2019, 224 p., pb., ill. 34,99 € (DE), 978-3-8376-4442-5 E-Book: PDF: 34,99 € (DE), ISBN 978-3-8394-4442-9 When the German chemist Emil Fischer presented his lock-and-key hypothesis in 1899, his analogy to describe the molecular relationship between enzymes and substrates quickly gained vast influence and provided future generations of scientists with a tool to investigate the relation between chemical structure and biological specificity. Rebecca Mertens explains the appeal of the lock-and-key analogy by its role in model building and in the construction of long-term, cross-generational research programs. She argues that a crucial feature of these research programs, namely ascertaining the continuity of core ideas and concepts, is provided by a certain way of analogy-based modelling. Rebecca Mertens (PhD), born in 1984, is a postdoctoral researcher in the history and philosophy of science at the University of Bielefeld, Germany. She works on the role of analogies, models and forms of comparison in the history of molecular genetics and is a member of the collaborative research program "Practices of ComparisonÚ Ordering and Changing the World". During her graduate and doctoral studies, she was a visiting scholar at the École Normale Supérieure in Paris and a visiting graduate fellow at the Minnesota Center for Philosophy of Science. For further information: www.transcript-verlag.de/en/978-3-8376-4442-5 © 2019
    [Show full text]
  • Lecture Program
    EARL W. SUTHERLAND LECTURE EARL W. SUTHERLAND LECTURE The Earl W. Sutherland Lecture Series was established by the SPONSORED BY: Department of Molecular Physiology and Biophysics in 1997 DEPARTMENT OF MOLECULAR PHYSIOLOGY AND BIOPHYSICS to honor Dr. Sutherland, a former member of this department and winner of the 1971 Nobel Prize in Physiology or Medicine. This series highlights important advances in cell signaling. ROBERT J. LEFKOWITZ, MD NOBEL PRIZE IN CHEMISTRY, 2012 SPEAKERS IN THIS SERIES HAVE INCLUDED: SEVEN TRANSMEMBRANE RECEPTORS Edmond H. Fischer (1997) Alfred G. Gilman (1999) Ferid Murad (2001) Louis J. Ignarro (2003) MARCH 31, 2016 Paul Greengard (2007) 4:00 P.M. 208 LIGHT HALL Eric Kandel (2009) Roger Tsien (2011) Michael S. Brown (2013) 867-2923-Institution-Discovery Lecture Series-Lefkowitz-BK-CH.indd 1 3/11/16 9:39 AM EARL W. SUTHERLAND, 1915-1974 ROBERT J. LEFKOWITZ, MD JAMES B. DUKE PROFESSOR, Earl W. Sutherland grew up in Burlingame, Kansas, a small farming community DUKE UNIVERSITY MEDICAL CENTER that nourished his love for the outdoors and fishing, which he retained throughout INVESTIGATOR, HOWARD HUGHES MEDICAL INSTITUTE his life. He graduated from Washburn College in 1937 and then received his MEMBER, NATIONAL ACADEMY OF SCIENCES M.D. from Washington University School of Medicine in 1942. After serving as a MEMBER, INSTITUTE OF MEDICINE medical officer during World War II, he returned to Washington University to train NOBEL PRIZE IN CHEMISTRY, 2012 with Carl and Gerty Cori. During those years he was influenced by his interactions with such eminent scientists as Louis Leloir, Herman Kalckar, Severo Ochoa, Arthur Kornberg, Christian deDuve, Sidney Colowick, Edwin Krebs, Theodore Robert J.
    [Show full text]
  • Past Recipients (Listed with Their Titles at the Time the Honor Was Conferred)
    Past Recipients (listed with their titles at the time the honor was conferred) 2014 José Jalife, M.D. Professor of Internal Medicine and The Cyrus and Jane Farrehi Professor of Cardiovascular Research Professor of Molecular & Integrative Physiology Director, Center for Arrhytmia Research University of Michigan 2012 Andras Nagy, Ph.D. Professor, Department of Molecular Genetics, Senior Investigator, Samuel Lunenfeld Research Institute University of Toronto 2010 Kevin P. Campbell, Ph.D. Professor, Department of Internal Medicine, Director, Wellstone Muscular Dystrophy Cooperative Research Center and Chair, Department of Molecular Physiology and Biophysics University of Iowa 2009 Friedrich C. Luft, M.D. Professor of Medicine and Director of the Experimental and Clinical Research Center at the Max-Delbruck Center for Molecular Medicine, Berlin, Germany Chief of Nephrology and Hypertension HELIOS Hospital in Berlin-Buch, Germany 2007 Howard J. Jacob, Ph.D. Director, Human and Molecular Genetics Center Warren P. Knowles Chair in Genetics Medical College of Wisconsin Milwaukee, Wisconsin 2005 John L. Hall, Ph.D. Arthur C. Guyton Professor and Chair Department of Physiology and Biophysics Director of the Center of Excellence in Cardiovascular-Renal Research Associate Vice-Chancellor of Research University of Mississippi Medical Center Jackson, Mississippi 2003 Gabor Kaley, Ph.D. Professor and Chairman Department of Physiology New York Medical College Valhalla, New York 2000 Hermes A. Kontos, M.D., Ph.D. Vice President for Health Sciences Dean, School of Medicine Virginia Commonwealth University School of Medicine Richmond, Virginia 1998 William J. Koopman, M.D. Chairman, Department of Medicine University of Alabama School of Medicine Birmingham, Alabama 1995 Suzanne Oparil, M.D.
    [Show full text]
  • 2012 Annual Report
    Memorial Sloan-Kettering Cancer Center 2012 ANNUAL REPORT A SHARED VISION A SINGULAR MISSION Nurse practitioner Naomi Cazeau, of the Adult Bone Marrow Transplant Service. PING CHI PHYSICIAN-SCIENTIST 10 STEPHEN SOLOMON ALEXANDER RUDENSKY INTERVENTIONAL IMMUNOLOGIST RADIOLOGIST 16 12 VIVIANE TABAR The clinicians and scientists of NEUROSURGEON Memorial Sloan-Kettering share a vision and 18 a singular mission — to conquer cancer. STEPHEN LONG STRUCTURAL BIOLOGIST They are experts united against a 20 SIMON POWELL complex disease. Each type of cancer R ADIATION ONCOLOGIST 24 ETHEL LAW is different, each tumor is unique. Set free NURSE PRACTITIONER in surroundings that invite the sharing of 26 ideas and resources, they attack the CHRISTINA LESLIE complexity of cancer from every angle COMPUTATIONAL BIOLOGIST and every discipline. 34 SCOTT ARMSTRONG PEDIATRIC ONCOLOGIST 30 TO JORGE REIS-FILHO EXPERIMENTAL PATHOLOGIST CONQUER 38 CANCER 04 Letter from the Chairman and the President A complete version of this report — 42 Statistical Profile which includes lists of our donors, 44 Financial Summary doctors, and scientists — 46 Boards of Overseers and Managers is available on our website at 49 The Campaign for Memorial Sloan-Kettering www.mskcc.org/annualreport. 4 5 Letter from the Chairman In 2012 the leadership of Memorial Sloan-Kettering endorsed Douglas A. Warner III These programmatic investments require leadership and and the President a $2.2 billion investment in a clinical expansion that will set vision. Our new Physician-in-Chief, José Baselga, joined the stage for a changing care paradigm into the next decade us on January 1, 2013. An internationally recognized and beyond.
    [Show full text]
  • 1 History for Canonical and Non-Canonical Structures of Nucleic Acids
    1 1 History for Canonical and Non-canonical Structures of Nucleic Acids The main points of the learning: Understand canonical and non-canonical structures of nucleic acids and think of historical scientists in the research field of nucleic acids. 1.1 Introduction This book is to interpret the non-canonical structures and their stabilities of nucleic acids from the viewpoint of the chemistry and study their biological significances. There is more than 60 years’ history after the discovery of the double helix DNA structure by James Dewey Watson and Francis Harry Compton Crick in 1953, and chemical biology of nucleic acids is facing a new aspect today. Through this book, I expect that readers understand how the uncommon structure of nucleic acids became one of the common structures that fascinate us now. In this chapter, I introduce the history of nucleic acid structures and the perspective of research for non-canonical nucleic acid structures (see also Chapter 15). 1.2 History of Duplex The opening of the history of genetics was mainly done by three researchers. Charles Robert Darwin, who was a scientist of natural science, pioneered genetics. The proposition of genetic concept is indicated in his book On the Origin of Species published in 1859. He indicated the theory of biological evolution, which is the basic scientific hypothesis of natural diversity. In other words, he proposed biological evolution, which changed among individuals by adapting to the environment and be passed on to the next generation. However, that was still a primitive idea for the genetic concept. After that, Gregor Johann Mendel, who was a priest in Brno, Czech Republic, confirmed the mechanism of gene evolution by using “factor” inherited from parent to children using pea plant in 1865.
    [Show full text]
  • 2004 Albert Lasker Nomination Form
    albert and mary lasker foundation 110 East 42nd Street Suite 1300 New York, ny 10017 November 3, 2003 tel 212 286-0222 fax 212 286-0924 Greetings: www.laskerfoundation.org james w. fordyce On behalf of the Albert and Mary Lasker Foundation, I invite you to submit a nomination Chairman neen hunt, ed.d. for the 2004 Albert Lasker Medical Research Awards. President mrs. anne b. fordyce The Awards will be offered in three categories: Basic Medical Research, Clinical Medical Vice President Research, and Special Achievement in Medical Science. This is the 59th year of these christopher w. brody Treasurer awards. Since the program was first established in 1944, 68 Lasker Laureates have later w. michael brown Secretary won Nobel Prizes. Additional information on previous Lasker Laureates can be found jordan u. gutterman, m.d. online at our web site http://www.laskerfoundation.org. Representative Albert Lasker Medical Research Awards Program Nominations that have been made in previous years may be updated and resubmitted in purnell w. choppin, m.d. accordance with the instructions on page 2 of this nomination booklet. daniel e. koshland, jr., ph.d. mrs. william mccormick blair, jr. the honorable mark o. hatfied Nominations should be received by the Foundation no later than February 2, 2004. Directors Emeritus A distinguished panel of jurors will select the scientists to be honored. The 2004 Albert Lasker Medical Research Awards will be presented at a luncheon ceremony given by the Foundation in New York City on Friday, October 1, 2004. Sincerely, Joseph L. Goldstein, M.D. Chairman, Awards Jury Albert Lasker Medical Research Awards ALBERT LASKER MEDICAL2004 RESEARCH AWARDS PURPOSE AND DESCRIPTION OF THE AWARDS The major purpose of these Awards is to recognize and honor individuals who have made signifi- cant contributions in basic or clinical research in diseases that are the main cause of death and disability.
    [Show full text]
  • Running with (CRISPR) Scissors: Tool Adoption and Team Assembly
    Running with (CRISPR) Scissors: Tool Adoption and Team Assembly Samantha Zyontz* MIT Sloan School of Management May 2019 Abstract Research tools are essential inputs to technological progress. Yet many new tools require specialized complementary know-how to be applied effectively. Teams in any research domain face the tradeoff of either acquiring this know-how themselves or working with external tool specialists, individuals with tool know-how independent of a domain. These specialists are scarce early on and can choose domain teams to create many applications for the tool or to focus on complicated problems. Ex ante it is unclear where the match between domain teams and external tool specialists dominates. The introduction of the DNA-editing tool CRISPR enables identification of external tool specialists on research teams by exploiting natural difficulties of applying CRISPR across disease domains. Teams have a higher share of external tool specialists in difficult diseases, especially for subsequent innovations. This suggests that external tool specialists and domain teams match more often to solve complex but influential problems. As more tools like Artificial Intelligence emerge, research teams will have to also weigh the importance of their possible solutions when considering how best to attract and collaborate with external tool specialists. * Ph.D. Candidate, MIT Sloan School of Management, Technological Innovation, Entrepreneurship, and Strategic Management. I am indebted to Scott Stern, Pierre Azoulay, Jeff Furman, Florenta Teodoridis, Michael Bikard, Danielle Li, and Tim Simcoe for their guidance and suggestions that immensely improved this paper. Appreciation also belongs to Joanne Kamens and her staff at Addgene, Aditya Kunjapur, Wes Greenblatt, and other CRISPR scientists for helping me to understand the science and institutions in this setting.
    [Show full text]
  • Crucible of Science: the Story of the Cori Laboratory
    Crucible of Science This page intentionally left blank Crucible of Science THE STORY OF THE CORI LABORATORY JOHN H. EXTON 3 3 Oxford University Press is a department of the University of Oxford. It furthers the University’s objective of excellence in research, scholarship, and education by publishing worldwide. Oxford New York Auckland Cape Town Dar es Salaam Hong Kong Karachi Kuala Lumpur Madrid Melbourne Mexico City Nairobi New Delhi Shanghai Taipei Toronto With offi ces in Argentina Austria Brazil Chile Czech Republic France Greece Guatemala Hungary Italy Japan Poland Portugal Singapore South Korea Switzerland Th ailand Turkey Ukraine Vietnam Oxford is a registered trademark of Oxford University Press in the UK and certain other countries. Published in the United States of America by Oxford University Press 198 Madison Avenue, New York, NY 10016 © Oxford University Press 2013 All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitt ed, in any form or by any means, without the prior permission in writing of Oxford University Press, or as expressly permitt ed by law, by license, or under terms agreed with the appropriate reproduction rights organization. Inquiries concerning reproduction outside the scope of the above should be sent to the Rights Department, Oxford University Press, at the address above. You must not circulate this work in any other form and you must impose this same condition on any acquirer. CIP data is on fi le at the Library of Congress ISBN 978–0–19–986107–1 9 8 7 6 5 4 3 2 1 Printed in the United States of America on acid-free paper Dedicated to Charles Rawlinson (Rollo) Park This page intentionally left blank Contents Acknowledgments ix I n t r o d u c t i o n xi 1.
    [Show full text]
  • Moore Noller
    2002 Ada Doisy Lectures Ada Doisy Lecturers 2003 in BIOCHEMISTRY Sponsored by the Department of Biochemistry • University of Illinois at Urbana-Champaign Dr. Peter B. 1970-71 Charles Huggins* and Elwood V. Jensen A76 1972-73 Paul Berg* and Walter Gilbert* Moore 1973-74 Saul Roseman and Bruce Ames Department of Molecular carbonyl Biophysics & Biochemistry Phe 1974-75 Arthur Kornberg* and Osamu Hayaishi Yale University C75 1976-77 Luis F. Leloir* New Haven, Connecticutt 1977-78 Albert L. Lehninger and Efraim Racker 2' OH attacking 1978-79 Donald D. Brown and Herbert Boyer amino N3 Tyr 1979-80 Charles Yanofsky A76 4:00 p.m. A2486 1980-81 Leroy E. Hood Thursday, May 1, 2003 (2491) 1983-84 Joseph L. Goldstein* and Michael S. Brown* Medical Sciences Auditorium 1984-85 Joan Steitz and Phillip Sharp* Structure and Function in 1985-86 Stephen J. Benkovic and Jeremy R. Knowles the Large Ribosomal Subunit 1986-87 Tom Maniatis and Mark Ptashne 1988-89 J. Michael Bishop* and Harold E. Varmus* 1989-90 Kurt Wüthrich Dr. Harry F. 1990-91 Edmond H. Fischer* and Edwin G. Krebs* 1993-94 Bert W. O’Malley Noller 1994-95 Earl W. Davie and John W. Suttie Director, Center for Molecular Biology of RNA 1995-96 Richard J. Roberts* University of California, Santa Cruz 1996-97 Ronald M. Evans Santa Cruz, California 1998-99 Elizabeth H. Blackburn 1999-2000 Carl R. Woese and Norman R. Pace 2000-01 Willem P. C. Stemmer and Ronald W. Davis 2001-02 Janos K. Lanyi and Sir John E. Walker* 12:00 noon 2002-03 Peter B.
    [Show full text]